Biped.News intelligence
Humanoid Robot Stocks & ETFs in 2026
What humanoid robot stocks and ETFs can investors actually buy? Compare direct public developers, pending IPO and SPAC paths, humanoid-focused funds, suppliers and evidence-backed risks.
What can investors actually buy?
Verified 2026-08-21. Biped.News separates live exchange-traded access from IPO and SPAC milestones so a filing, pricing event or merger agreement is not mislabeled as a tradable robot-company stock.
| Company / path | Ticker | Exchange | Status | Directness | What investor access means | Evidence |
|---|---|---|---|---|---|---|
| Tesla | TSLA | NASDAQ | Trading | Diversified robot developer | Buy Tesla shares; Optimus is not separately listed. | Tesla officially describes Optimus as a general-purpose autonomous bipedal humanoid robot, but the robotics program remains part of a much larger EV, energy and autonomy business. Source |
| UBTECH Robotics | 9880.HK | HKEX | Trading | Robotics-centered listed developer | Hong Kong-listed shares provide one of the more direct current public humanoid exposures. | UBTECH is a listed robotics company with Walker-series humanoid programs and named industrial deployment evidence tracked by Biped.News. Source |
| Rainbow Robotics | 277810 | KOSDAQ | Trading | Listed robotics specialist | KOSDAQ-listed robotics equity; Samsung is the largest shareholder. | Rainbow Robotics was founded by the KAIST HUBO humanoid team and listed on KOSDAQ in 2021. Samsung increased its stake to 35% to accelerate future robots including humanoids. Source |
| XPENG | XPEV / 9868.HK | NYSE / HKEX | Trading | Diversified physical-AI developer | NYSE ADSs trade as XPEV; Hong Kong shares trade as 9868. | XPENG is developing the IRON humanoid and says its mass-production-ready version is targeted for formal mass production by the end of 2026, but autos still dominate the business. Source |
| Dobot Robotics | 02432.HK | HKEX | Trading | Listed robotics specialist | Hong Kong-listed H shares provide direct exposure to Dobot, whose current product catalog includes the ATOM humanoid. | HKEX lists Dobot under stock code 02432, while Dobot officially describes ATOM as its first full-size embodied-AI humanoid robot. Source |
| Unitree Robotics | 688836 | Shanghai STAR Market | Trading | Robotics-centered listed developer | Unitree A-shares began trading on Shanghai's STAR Market on August 19, 2026 under stock code 688836. Investor access depends on brokerage and market eligibility. | The Shanghai Stock Exchange records Unitree's August 19 listing ceremony, and market reporting verifies stock code 688836. The IPO was priced at RMB 150.80; first-day trading volatility is a market event, not evidence of robot deployment readiness or a Biped.News valuation recommendation. Source |
| Agility Robotics / Churchill Capital Corp XI | CCXI now; AGLT expected after closing | NASDAQ | SPAC transaction pending | Proposed U.S. pure-play | CCXI is Churchill Capital Corp XI today, not Agility common stock. Agility becomes public only if the business combination closes. | Churchill and Agility signed a merger agreement on June 24, 2026. A July 14 SEC filing and Agility update say a confidential draft Form S-4 was submitted; the transaction remains subject to closing conditions. Source |
How to read public access
Directness describes the relationship to humanoid robotics, not expected return. Diversified companies can have real robot programs while robotics remains financially immaterial.
- Trading: exchange-listed under the stated symbol.
- IPO watch: offering or listing process is underway, but trading is not yet verified.
- SPAC watch: the SPAC trades, but the robot company is not public until the business combination closes.
Humanoid-focused ETFs
Four issuer-verified funds currently target humanoid robotics or the surrounding physical-AI value chain. Broader BOTZ, ROBO, ARTY and ARKQ alternatives remain in the interactive investing hub.
| Fund | Ticker | Exchange | Style | Expense | Inception | Scope and caveat |
|---|---|---|---|---|---|---|
| KraneShares Global Humanoid Robotics and Physical AI Index ETF | KOID | NASDAQ | Index | 0.79% gross / 0.69% net as verified | 2025-06-04 | Humanoid developers plus the physical-AI brain, body, components and integrator ecosystem. Still a broad ecosystem basket rather than a portfolio of only pure-play humanoid makers. |
| Roundhill Humanoid Robotics ETF | HUMN | Cboe BZX | Active | 0.75% | 2025-06-26 | Actively managed exposure to humanoid developers and enabling physical-AI companies. Holdings and weights can change actively; verify the current portfolio before inferring company exposure. |
| Themes Humanoid Robotics ETF | BOTT | NASDAQ | Index | 0.35% | 2024-04-22 | Tracks the Solactive Global Humanoid Robotics Index across automation equipment, semiconductors and machine components. The fund predates its humanoid mandate: Themes says the underlying index changed to the humanoid index on August 19, 2025. |
| Global X Humanoid Robotics ETF | HMND | ASX | Index | 0.57% p.a. | 2026-03-26 | Australian-domiciled fund tracking the global humanoid robotics value chain. ASX-listed and AUD-denominated; access, tax and currency exposure differ from U.S.-listed funds. |
What remains on the full investing hub
The interactive page still includes delayed market prices and returns, public-company exposure filters, Biped investor-signal scores, supplier layers, funding and M&A signals, private-company watchlists and related reporting.
Download JSON snapshot · Download access CSV · Download ETF CSV
Methodology and limitations
Trading means shares or ETF units are currently exchange-listed under the stated symbol; pending IPO or SPAC stages are kept separate. Directness describes how closely the security's business is tied to humanoid robotics, not an expected return or recommendation. Developer exposure is separated from parent-company, supplier, AI infrastructure and broad automation exposure already mapped elsewhere on Biped.News. ETF scope, expense ratios and inception dates are taken from issuer pages and should be rechecked because holdings, fees and mandates can change.
- This is market research, not investment advice, a recommendation, valuation opinion or trading feed.
- A public company can have genuine humanoid exposure while humanoid revenue remains immaterial to its consolidated results.
- A priced IPO is not the same as shares beginning to trade; a SPAC agreement is not the same as a completed business combination.
- Foreign listings can introduce access, currency, liquidity, tax, policy and disclosure risks that this snapshot does not quantify.
- This snapshot is not a global census of every listed company with a robot project; it prioritizes higher-confidence developer exposure with current primary-source evidence.